0.1726
-0.0499
(-22.43%)
At close: January 30 at 8:03:32 AM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-59,987.0000
-126,792.0000
-125,263.0000
-116,559.0000
-85,527.0000
Investing Cash Flow
--
47.0000
-65.0000
-38.0000
75,991.0000
Financing Cash Flow
116,942.0000
-936.0000
-1,100.0000
184,871.0000
92,725.0000
End Cash Position
95,947.0000
21,855.0000
149,555.0000
261,599.0000
184,686.0000
Capital Expenditure
--
--
-65.0000
-38.0000
-397.0000
Issuance of Capital Stock
105,358.0000
89.0000
295.0000
199,483.0000
98,653.0000
Repurchase of Capital Stock
-34.0000
-89.0000
-295.0000
-397.0000
--
Free Cash Flow
-59,987.0000
-126,792.0000
-125,328.0000
-116,597.0000
-85,924.0000
12/31/2020 - 12/11/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PMRA.BE Pharma Mar SA
85.10
-1.10%
BITRF Biotron Limited
0.0497
0.00%
INNMF Amplia Therapeutics Limited
0.0450
0.00%
22Z.BE Zealand Pharma A/S
98.45
+0.87%
SCPS Scopus BioPharma Inc.
0.0003
0.00%
BIOAF Bioasis Technologies Inc.
0.0002
0.00%
CLABF Core One Labs Inc.
0.0366
-18.67%
KLDO Kaleido Biosciences, Inc.
0.0001
0.00%
WSNAF Wesana Health Holdings Inc.
0.0685
0.00%
BETRF BetterLife Pharma Inc.
0.1140
0.00%